Skip to the page

Data / Drug companies / Zydus Lifesciences Limited

Zydus Lifesciences Limited: 194 products in the FDA NDC directory, labeler code 65841

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Zydus Lifesciences Limited (labeler code 65841) lists 194 products in the FDA National Drug Code Directory, covering 43 finished drugs by generic name. By type: 132 prescription drugs, 62 bulk ingredients. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 16, 2026.

The request: Watch Zydus Lifesciences Limited (FDA labeler code 65841): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
65841
Products in commercial distribution
194
Packages
670
Finished drugs by generic name
43
Prescription products
132
Over the counter products
0
Flagged as original packager
132 of 132 products that carry the flag
Started marketing in the last 12 months
2
Earliest marketing start
September 28, 2005
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)13268%
Bulk ingredients6232%

Products by type

TypeProductsShare
Prescription drugs13268%
Bulk ingredients6232%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Powder6131.4%
Tablet4925.3%
Tablet, film coated4121.1%
Capsule147.2%
Tablet, extended release73.6%
Capsule, delayed release63.1%
Capsule, coated pellets42.1%
Capsule, extended release31.5%
Tablet, film coated, extended release31.5%
Tablet, orally disintegrating21%
Tablet, chewable21%
Tablet, coated10.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Phthaloyl amlodipine65841-301PowderBulk ingredientsSeptember 16, 2026
Omeprazole65841-401PowderBulk ingredientsAugust 25, 2026
Phenylbutazone65841-302PowderBulk ingredientsSeptember 27, 2025
Levofloxacin hemihydrate65841-011PowderBulk ingredientsMarch 7, 2025
Mirabegron65841-192PowderBulk ingredientsJanuary 2, 2025
Ranolazine65841-191PowderBulk ingredientsJanuary 2, 2025
Roflumilast65841-190PowderBulk ingredientsJanuary 2, 2025
Entecavir65841-185PowderBulk ingredientsJanuary 2, 2025
Clindamycin65841-180PowderBulk ingredientsJanuary 2, 2025
Febuxostat65841-179PowderBulk ingredientsJanuary 2, 2025
Lurasidone65841-188PowderBulk ingredientsDecember 27, 2024
Pitavastatin magnesium65841-183PowderBulk ingredientsDecember 27, 2024
Rivastigmine65841-184LiquidBulk ingredientsDecember 24, 2024
Tofacitinib citrate65841-194PowderBulk ingredientsDecember 21, 2024
Teriflunomide65841-193PowderBulk ingredientsDecember 21, 2024
Tizanidine hydrochloride65841-197PowderBulk ingredientsDecember 20, 2024
Trazodone hydrochloride65841-196PowderBulk ingredientsDecember 20, 2024
Azathioprine65841-195PowderBulk ingredientsDecember 20, 2024
Duloxetine hydrochloride65841-189PowderBulk ingredientsDecember 20, 2024
Fingolimod65841-187PowderBulk ingredientsDecember 20, 2024
Mesalamine65841-186PowderBulk ingredientsDecember 20, 2024
Esomeprazole magnesium dihydrate65841-182PowderBulk ingredientsDecember 20, 2024
Silodosin65841-181PowderBulk ingredientsDecember 19, 2024
Paroxetine hydrochloride hemihydrate65841-177PowderBulk ingredientsDecember 19, 2024
Metoprolol succinate65841-144PowderBulk ingredientsDecember 19, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.